> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Clears Viveve System for Vaginal Laxity
- URL: https://www.fdaweb.com/fda-clears-viveve-system-for-vaginal-laxity/
- Published: 2016-10-06T12:00:00.000Z
- Updated: 2026-09-14T21:37:45.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5137017

FDA has cleared a Viveve Medical 510(k) for the Viveve System for use in general surgical procedures for electrocoagulation and hemostasis in treating vaginal laxity. The device uses patented radiofrequency (RF) energy to stimulate the body’s natural collagen rebuilding processes in the vagina. A physician performs the procedure using the Viveve System that works by cooling and gently heating vaginal tissue. “This treatment option can increase feelings of vaginal tightness and improve sexual satisfaction” the company says.